Science Explorer Interactive view Map
Company · Seattle · United States

Atossa Therapeutics (United States)

atossatherapeutics.comROR OpenAlex
Research works
31
▲ 266% vs 2013–17
Citations
165
5.3 per fractional work
Top-10% rate
0.8%
record average 16.5%
Open access
68%
world 28%

Not ranked overall: Atossa Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 3.00× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 6.54× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 4.11× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 1.59× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.99× its world share, 0 worksChemistryMedicine: 2.32× its world share, 5 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 6.5×. Every wedge is a field page.

Who are the top researchers at Atossa Therapeutics (United States)?

Ranked on the composite score, Steven C. Quay lead among researchers whose main affiliation is Atossa Therapeutics (United States).

  1. 1 Steven C. Quay United States · #512,295 worldwide 45 citations · 36 works
All ranked researchers at Atossa Therapeutics (United States)

Which keywords describe research at Atossa Therapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Vaccine, Coronavirus, SARS-CoV-2, Deep Learning, Pandemic, COVID-19, ACE2 Receptor and Immunity.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Vaccine6▲ 47×4 topics
  2. Coronavirus6▲ 153×2 topics
  3. SARS-CoV-25▲ 106×3 topics
  4. Deep Learning4▲ 6.7×3 topics
  5. Pandemic4▲ 29×3 topics
  6. ACE2 Receptor4▲ 110×2 topics
  7. COVID-194▲ 19×3 topics
  8. Immunity4▲ 38×2 topics
  9. Convolutional Neural Networks4▲ 30×2 topics
  10. Viral Transmission4▲ 125×2 topics
  11. antibody4▲ 267×1 topic
  12. spike protein4▲ 267×1 topic
  13. Artificial Intelligence3▲ 13×2 topics
  14. Epidemiology3▲ 2.7×7 topics
  15. Breast Cancer3▲ 36×5 topics
  16. Chest X-Ray3▲ 363×1 topic
  17. Medical Imaging3▲ 33×1 topic
  18. Pathogenesis3▲ 16×4 topics
  19. Immune Response2▲ 13×4 topics
  20. Public Health2▲ 4.9×3 topics
  21. Circovirus2▲ 172×1 topic
  22. Porcine Reproductive and Respiratory Syndrome Virus2▲ 172×1 topic
  23. Gene Expression2▲ 9.4×2 topics
  24. Infectious Diseases2▲ 24×2 topics
  25. Nuclear Receptors2▲ 28×2 topics
  26. Radiotherapy2▲ 13×3 topics
  27. Disaster Response2▲ 63×1 topic
  28. Estrogen2▲ 65×1 topic
  29. Receptor2▲ 68×1 topic
  30. Triage2▲ 123×1 topic
  31. Biodiversity1▲ 6.0×2 topics
  32. Breast Tumours1▲ 84×1 topic
  33. Clinical Practice Guidelines1▲ 7.5×2 topics
  34. One Health1▲ 181×1 topic
  35. Treatment Response1▲ 84×1 topic
  36. Zoonotic Diseases1▲ 181×1 topic
  37. Stem Cells1▲ 13×2 topics
  38. Therapeutic Targets1▲ 16×2 topics
  39. Cell Proliferation1▲ 38×2 topics
  40. Histopathology Images1▲ 89×1 topic

Which research topics does Atossa Therapeutics (United States) publish most on?

By volume in 2022–2025: Hippo pathway signaling and YAP/TAZ, Adenosine and Purinergic Signaling, SARS-CoV-2 and COVID-19 Research and Estrogen and related hormone effects.

Hippo pathway signaling …1Hippo pathway signaling and YAP/TAZ: 1 fractional worksAdenosine and Purinergic…1Adenosine and Purinergic Signaling: 1 fractional worksSARS-CoV-2 and COVID-19 …1SARS-CoV-2 and COVID-19 Research: 1 fractional worksEstrogen and related hor…1Estrogen and related hormone effects: 1 fractional worksPlant Virus Research Studies: 1 fractional worksAnimal Virus Infections Studies: 1 fractional worksCOVID-19 diagnosis using…0COVID-19 diagnosis using AI: 0 fractional worksSARS-CoV-2 detection and testing: 0 fractional worksData-Driven Disease Surveillance: 0 fractional worksCAR-T cell therapy research: 0 fractional works
Cell BiologyPhysiologyInfectious DiseasesGenetics5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Hippo pathway signaling and YAP/TAZ Cell Biology 1 works
  2. 2 Adenosine and Purinergic Signaling Physiology 1 works
  3. 3 SARS-CoV-2 and COVID-19 Research Infectious Diseases 1 works
  4. 4 Estrogen and related hormone effects Genetics 1 works
  5. 5 Plant Virus Research Studies Plant Science 1 works
  6. 6 Animal Virus Infections Studies Animal Science and Zoology 1 works
  7. 7 COVID-19 diagnosis using AI Radiology, Nuclear Medicine and Imaging 0 works
  8. 8 SARS-CoV-2 detection and testing Infectious Diseases 0 works
  9. 9 Data-Driven Disease Surveillance Epidemiology 0 works
  10. 10 CAR-T cell therapy research Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available68.3%not open31.7%

World: 28% of research is openly available.

with international co-authors28.9%domestic only71.1%

World: 19% is written across borders.

How has Atossa Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 266% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Seattle

All research institutions in Seattle

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.